Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neutropenia 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

liposomal amphotericin B 2Cytarabine 2lintuzumab 1isavuconazole 1Voriconazole 1Vegetables 1Moxifloxacin 1Mitoxantrone 1Mannose-Binding Lectin 1Levofloxacin 1Lenalidomide 1Idarubicin 1Filgrastim 1Etoposide 1Clofarabine 1Ciprofloxacin 1Cefepime 1Caspofungin 1Amoxicillin-Potassium Clavulanate Combination 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × isavuconazole × Myeloid × Clear all
NCT03019939 2021-10-26

Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia

M.D. Anderson Cancer Center

Phase 2 Completed
65 enrolled 17 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡